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 Th e RDRTF has established a framework 
of  ‘ to do ’ items, based on expertise gained 
during and between disasters, and includ-
ing non-nephrological issues such as trans-
port and logistics. Although every disaster 
is diff erent, 3 these scenarios provide infor-
mation on what can be done by whom, 
without time being lost in fruitless discus-
sions. This helps to avoid the so-called 
second-disaster eff ect created by swarms 
of rescue teams without a clear plan. 
 Th is expertise lies at the basis of com-
prehensive recommendations that are cur-
rently being prepared by the RDRTF of 
the ISN. These will cover all disaster-
related aspects of kidney disease and 
crush, including extrication, fl uid admin-
istration, overall therapeutic and diagnos-
tic aspects, dialysis for acute and chronic 
kidney problems, and advance planning. 
Recommendations on specifi c dialysis-
related aspects of disasters were developed 
in the United States aft er Katrina. 15 Hope-
fully, these initiatives will be helpful in 
further improving the outcomes of renal 
patients in disaster circumstances. 
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 Regulatory T cells (Tregs) are key regula-
tors of immunological function, including 
tolerance. Tregs have been demonstrated to 
ameliorate injury in several murine exper-
imental models of renal infl ammation, such 
as adriamycin nephropathy 1 and nephro-
toxic nephritis. 2 Many recent studies have 
demonstrated that T cells and B cells of the 
adaptive immune system make a signifi cant 
contribution to the severity of renal 
ischemia – reperfusion injury (reviewed by 
Linfert  et al. 3 ), and the involvement of Tregs 
in the modulation of acute kidney injury is 
thus not unreasonable. Now, however, 
 Gandolfo  et al. 4 (this issue) describe the key 
role played by Tregs in modulating recov-
ery from ischemic renal injury. They 
 demonstrate that Tregs are present in aug-
mented numbers within postischemic kid-
ney at both 3 and 10 days after injury. 
Anti-CD25 antibody (PC61) was then used 
to  eff ectively deplete Tregs  in vivo , with 
treatment commencing at the 24-hour time 
point — that is, aft er the period of maximal 
injury — so that Treg depletion occurred 
during the recovery phase of ischemia –
 reperfusion injury. This resulted in 
 prolongation of structural injury and a 
reduction in tubular proliferation in both 
the cortex and the medulla that was associ-
ated with increased intra cellular expression 
of tumor necrosis factor-  and interferon-  
by infi ltrating T cells. Depletion of Tregs 
increased mortality and serum creatinine 
level at day 2 after renal ischemia –
 reperfusion injury. Compellingly, when 
Tregs from naive animals were isolated 
from the spleen and infused into 
 postischemic host mice, there was a sig-
nifi cant improvement in the tubular injury 
scores, with augmented tubular prolifera-
tion, diminished cytokine expression by 
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infi ltrating T cells, and a slight improve-
ment in serum creatinine in the late recov-
ery phase. Intriguingly, the depletion or 
administration of Tregs exerted a minimal 
eff ect on the numbers of other renal leuko-
cytes such as neutrophils, macrophages, 
and so on. 
 Th e work of Gandolfo and colleagues 4 
complements the recent studies of Kinsey 
 et al. , 5 who also used the PC61 anti-CD25 
antibody to deplete Tregs but administered 
the antibody before induction of renal 
ischemia – reperfusion injury. Treg-depleted 
mice developed increased renal failure and 
more severe acute tubular necrosis. Injured 
kidneys exhibited increased neutrophil and 
macrophage infi ltration (but not CD4   +   T-
cell or B-cell infiltration) and increased 
interleukin (IL)-6, tumor necrosis factor-  , 
and transforming growth factor-  (TGF-  ) 
gene expression (but not IL-10 gene expres-
sion). Furthermore, Kinsey  et al. explored 
the eff ect of Tregs in T- and B-cell-defi cient 
RAG-1 knockout mice that had been recon-
stituted with lymph node cells from either 
wild-type mice or Foxp3-defi cient Scurfy 
mice. 5 RAG-1 mice reconstituted with wild-
type cells developed renal failure and renal 
injury following renal ischemia – reperfusion 
injury in contrast to control RAG-1 knock-
out mice, which were  protected from 
ischemic renal injury. However, RAG-1 
mice reconstituted with Foxp3-defi cient 
cells exhibited markedly increased renal 
failure and neutrophil / macrophage infi ltra-
tion as compared with RAG-1 mice recon-
stituted with wild-type cells, thereby 
suggesting that fully functional Tregs 
actively suppress kidney injury following 
renal ischemia – reperfusion injury. 
 What are the key mediators of  Tregs? 
 Th us Tregs appear to exert benefi cial ef-
fects in both the acute injury phase and 
the recovery phase of renal ischemia –
 reperfusion injury. What mediators may 
be responsible for these actions? In the 
studies of Kinsey  et al. , RAG-1 mice ex-
posed to more prolonged renal ischemia –
 reperfusion injury (in order to induce 
signifi cant injury) were functionally and 
histologically protected by the adoptive 
transfer of wild-type Tregs. 5 Th is pro-
tective eff ect, however, was lost if IL-10 
knockout Tregs were administered, thus 
implicating IL-10 as a key mediator of 
Treg protection in this model 5 ( Figure 1 ). 
Th e role of IL-10 production by Tregs re-
mains unclear in the study by Gandolfo 
and colleagues, as IL-10 expression was 
markedly increased in the aft ermath of 
Treg depletion in the recovery phase of re-
nal ischemia – reperfusion injury. 4 In con-
trast, Mahajan  et al. demonstrated that the 
protective eff ect of Treg transfer to SCID 
mice with adriamycin nephropathy could 
be abrogated by anti-TGF-  antibodies, 
suggesting that TGF-  may also mediate 
the anti-infl ammatory function of Tregs. 1 
 Tregs and ischemic injury of other organs 
 Ischemia – reperfusion injury is a common 
cause of acute dysfunction in many major 
organ systems, including the kidney, heart, 
liver, and brain. Do Tregs deliver a similar 
benefi cial contribution to injury states 
such as myocardial infarction, hepatic 
ischemia, and cerebral stroke? Although 
the currently available data are limited, 
experimental work does suggest that 
Tregs may act to dampen ischemic injury 
in other organs. For example, as with  renal 
ischemia – reperfusion injury, Treg deple-
tion worsens outcome in a murine model 
of experimental stroke, with the genera-
tion of IL-10 by recruited Tregs being crit-
ical to their benefi cial anti-infl ammatory 
eff ect. 6 Interestingly, oral tolerization of 
mice to central nervous system proteins 
generates IL-10-producing CD4   +   T cells, 
which, aft er adoptive transfer, were capa-
ble of reducing the susceptibility to stroke 
in recipient animals. 7 However, studies 
in murine hepatic ischemia – reperfusion 
injury have demonstrated no protection 
from Treg depletion with the use of the 
same PC61 anti-CD25 antibody. 8 Th is 
fi nding may illustrate either the diff er-
ences that exist in immune-cell activation 
between diff erent solid organs, or indeed 
the limitations of incomplete antibody-
based depletion in characterizing the role 
of a cell lineage capable of exerting large 
biological eff ects while constituting  a tiny 
proportion of the total cell population. 
Although anti-CD25 antibody – mediated 
Treg depletion did not ameliorate hepatic 
ischemia – reperfusion injury, 8 the im-
munosuppressive agents tacrolimus and 
sirolimus do protect rats from hepatic 
ischemia – reperfusion injury; an increase 
in the proportion of intrahepatic Tregs 
and a reduction in the Th 1 / Th 2 ratio are 
suggested to play a role in this protective 
action. 9  To our knowledge, the role of 
Tregs in the reparative responses of these 
various organs, as opposed to acute tissue 
injury, has not been studied. 
 Do Tregs act as a brake on tissue injury, 
or do they actively stimulate repair? 
 Th e data presented by Gandolfo  et al. 4 
build on other recent work to make a 
compelling case implicating the Treg as 
a genuinely benefi cial force in both the 
initiation and the repair phases of renal 
ischemia – reperfusion injury. Th is conclu-
sion is based on studies demonstrating an 
exaggerated injury phenotype and delayed 
markers of tubular regeneration in animals 
 Figure 1  |  The potential role of regulatory T cells and putative mediators in limiting tissue 
injury in renal ischemia – reperfusion injury and promoting parenchymal repair . IL-10, 
interleukin-10; TGF-  , transforming growth factor-  . 
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either lacking fully functional Tregs or 
rendered Treg defi cient via anti-CD25 
antibody-induced depletion. It is striking 
that Tregs resident within an anatomically 
remote site such as the spleen were capa-
ble of assisting in recovery when infused 
into donor animals to eff ectively augment 
the total  ‘ pool ’ of Tregs. Th is intriguing 
fi nding would suggest that Tregs  per se of-
fer protection from ischemia – reperfusion 
injury distinct from any antigen specifi ci-
ty, and further blurs distinctions between 
the innate and adaptive immune systems. 
 It should be noted, however, that the 
phases of acute injury and repair typically 
overlap within the tissues of all injured 
organs. Th us, although the depletion of 
Tregs before the induction of tissue injury 
is eminently feasible, 5 the depletion of 
Tregs at the exact and  ‘ non-overlapping ’ 
interface between injury and repair is 
more problematic. Th us, the benefi cial 
eff ect of Tregs on the recovery phase of 
renal injury that is evident in the study by 
Gandolfo  et al. 4 may partly result from an 
inhibitory impact of Tregs on ongoing 
acute infl ammatory processes within the 
kidney as suggested by the eff ects on T-
cell cytokines at the later time points. In 
other words, the prolonged injury phe-
notype may represent the negative eff ects 
of excessive ongoing activation of the 
eff ector arms of both innate and adaptive 
immune systems in the absence of anti-
infl ammatory Tregs. Alternatively, Tregs 
may have the capacity to actively promote 
tissue repair  processes, either directly by 
the release of factors promoting renal-cell 
survival and replication, or indeed by 
modifying the phenotype of other infi l-
trating cells implicated in mediating 
recovery from renal ischemia – reper-
fusion injury, such as macrophages. 10 As 
such, whether Tregs act as a generalized 
 ‘ cellular brake ’ to limit immune-cell acti-
vation, or as a more subtle conductor of 
the intrinsic renal reparative response to 
injury, merits further study. 
 Conclusion 
 Tregs are eminently suitable for the fi eld 
of transplantation, where the prevention 
of delayed graft  function resulting from 
ischemia – reperfusion injury and the in-
duction of tolerogenic immune responses 
are desirable. It is thus of interest that the 
coadministration of Tregs with pancreatic 
islets limits the initial acute islet injury and 
promotes successful engraft ment. 11 Clearly, 
there is a huge unmet clinical need for inter-
ventions that induce the resolution of renal 
injury, and the potential future harnessing 
of Tregs for therapeutic gain in acute kid-
ney injury is an attractive prospect. Further 
interrogation of the mechanisms by which 
Tregs facilitate and promote renal recovery 
will be needed to allow any translational 
potential to be realized. 
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 Th e maintenance of systemic acid – base 
balance within very narrow limits is essen-
tial for life. However, the development of 
metabolic acidosis, which is characterized 
by a decrease in plasma pH and bicarbo-
nate ions, is a common clinical condition. 1 
Metabolic acidosis is caused by the over-
production of acid due to a high-protein 
diet; increased catabolism of endogenous 
proteins during sepsis, cachexia, or pro-
longed fasting; and various alterations in 
metabolism, such as diabetic ketoacidosis, 
lactic acidosis, or genetically determined 
acidurias. It also results from loss of base 
due to excessive diarrhea or renal defects 
in bicarbonate reabsorption. Th e onset of 
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 Szutkowska  et al . demonstrate that   -crystallin plays an essential role in 
the stabilization of the Na + /K + /2Cl −  cotransporter mRNA in the 
medullary thick ascending limb. However, diff erential eff ects of 
experiments using small interfering RNA to knock down   -crystallin in 
proximal tubule and thick ascending limb cells suggest that additional 
proteins must contribute to the rapid turnover and selective 
stabilization of the various mRNAs during metabolic acidosis. 
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